Sustained-release indomethacin in the management of the acute painful shoulder from bursitis and/or tendinitis.
Of all the forms of nonarticular rheumatism, by far the most common are bursitis and tendinitis. Yet, the bursae and neighboring tendon sheaths are the most neglected anatomic structures of the body. Moreover, like the joints, they are lined by synovial membrane, secrete synovial fluid, and are common sites of rheumatic problems. The vast majority of painful shoulder problems are caused by acute subacromial (subdeltoid) bursitis and bicipital tendinitis. In the management of these periarticular disorders, the ultimate goal is to preserve shoulder motion. Although this is accomplished by daily range-of-motion exercises, it is clearly facilitated by suppression of periarticular inflammation and discomfort through the use of nonsteroidal anti-inflammatory drugs. Of these, sustained-release indomethacin provides the anti-inflammatory efficacy of indomethacin and by virtue of its sustained-release formulation, may promote patient compliance since it need be given only once or twice daily.
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002062:Bursitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003692:Delayed-Action Preparations; D003937:Diagnosis, Differential; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D010353:Patient Education as Topic; D012785:Shoulder Joint / Q000033:anatomy & histology; D052256:Tendinopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D007213:Indomethacin